SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genta, Inc. (GNTA)
GNTA 2.040+5.2%Nov 28 12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David C who wrote (1266)12/29/1999 1:35:00 AM
From: billkirn   of 1870
 
Dave:
My take on the future price of Genta would be limited somewhat because it is a one drug, potentially great drug, company with no long term research potential. No pipe line for future products. So if their drug is as successful as I think it will be, the stock may reach 35 to 40 max. over the next 3 years. Things may change if they can generate revenue, elevate their stock price, maybe buy some promising biotech companies like ISIS in a few years.
Good Luck

Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext